Daniel L. Zheng
FDA Investigator
- Daniel L. Zheng first started conducting FDA inspections in 2020, with the last inspection in 2024. Over that time, Daniel L. Zheng has conducted 24 inspections at 21 companies across 23 sites.
Get Daniel Zheng's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Denison Pharmaceuticals, LLC, Lincoln | 2024
Out of stock
FDA 483 Novel Laboratories, Inc. d.b.a Lupin Somerset, Somerset | 2024
Out of stock
FDA 483 EyePoint Pharmaceuticals, Inc., Watertown | 2024
Out of stock
FDA 483 Apothecus Pharmaceutical Corp., Hicksville | 2023
Out of stock
FDA 483 Lohxa, LLC, Worcester | 2023
Out of stock
FDA 483 Pharmasol Corporation, South Easton | 2021
Out of stock
Co-Investigators (14)
- Lori M. Newman, FDA Investigator
- Ifechimere I. Okafor, FDA Investigator
- Suchan Kim, FDA Investigator
- Sean R. Marcsisin, FDA Investigator
- Armen H. Youssoufian, FDA Investigator
- James R. Birkenstamm, FDA Investigator
- Ruben C. Quintana, FDA Investigator
- Yoriann M. Cabrera Bartolomei, FDA Investigator
- Erik W. Koester, FDA Investigator
- Robert J. Martin, FDA Investigator
- Jonathan G. Matrisciano, FDA Investigator
- Terry Bridgewater, FDA Investigator
- Leanna M. Slarsky, FDA Investigator
- Mindy M. Chou, FDA Investigator